Thursday brought yet more merger and acquisition news in the ongoing buyout trends in the biotech sector. Amgen Inc. (NASDAQ: AMGN) announced that it is going to acquire Micromet, Inc. (NASDAQ: MITI), a cancer drug…
The Medco Health Solutions Inc. (NYSE: MHS) and Express Scripts Inc. (NASDAQ: ESRX) merger saga is one which may go down in the financial history books for one of the more long and drawn…
The tide of patent expirations that is washing over big pharmaceutical houses is cresting now and investors have begun looking forward to how these companies will deal with some sharp blows to their revenues…
Personalized medicine is coming… if you can afford it. The quest for the $1,000 genomic map has been a race and it appears to be closer and closer. News is out from Life Technologies that…
It takes a recession to slow what has normally been runaway U.S. health care costs. The trend may be part of a road map to keep costs down. These costs have risen at close to double…
Dendreon (NASDAQ: DNDN) soared almost 40% in value, or $3.02 a share, in active trading on Thursday after announcing that fourth-quarter revenue from its Provenge prostate-cancer vaccine would exceed earlier forecasts. Looking to 2012,…
Dendreon Corporation (NASDAQ: DNDN) is living up to something we showed late in December. It was one of the Top Biotech Upside Stocks for 2012 by Wall Street Analysts. Now, the question is whether…
For several years it has been the case that Amgen Inc. (NASDAQ: AMGN) was considered a biotech though it had at least some of the same problems of Big Pharma players like Pfizer Inc. (NYSE: PFE)…
The biotech sector has seen its share of ups and downs in 2011 and prior years. It is almost always the case that some of the top performing stocks each year come from this…
Over the last week we have been reviewing some of the “Small Cap Stocking Stuffers” that features the top small cap ideas for 2012 from Credit Suisse. After reviewing the list, it turned out…
Many research firms have been coming up with their best ideas lists for 2012. Today brought a list of top picks in the medical technology and medical devices sector from Zacks Investment Research. We…
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) is raising cash to help support the commercialization of ponatinib in patients with resistant or intolerant CML and additional clinical development of its investigational targeted cancer medicines. All of…
Some rumors surrounding the world of mergers and acquisitions actually do manage to come true. The newest deal to hit the tape is an acquisition by FUJIFILM Holdings Corporation of SonoSite, Inc. (NASDAQ: SONO). The healthcare…
Human Genome Sciences Inc. (NASDAQ: HGSI) is not getting much of a boost despite being called as stock which could manage to double in price over the next 18 months by Barron’s. Usually such…
We recently gave a full review of the DJIA components we expect to raise their dividend payouts in the weeks and months ahead. Among those we expect to raise the dividend is Pfizer Inc.…